METHODS:
The enrollment goal of 14,000 RBC donors across four centers, with characterization of RBC hemolysis across two testing laboratories, required rigorous piloting and optimization and establishment of a quality assurance (QA) and quality control (QC) program. Optimization of WBC elution from leukoreduction (LR) filters, development and validation of small-volume transfer bags, impact of manufacturing and sample-handling procedures on hemolysis parameters, and testing consistency across laboratories and technicians and over time were part of this quality assurance/ quality control program.
RESULTS: LR filter elution procedures were optimized for obtaining DNA for analysis. Significant differences between standard and pediatric storage bags led to use of an alternative LR-RBC transfer bag. The impact of sample preparation and freezing methods on metabolomics analyses was evaluated. Proficiency testing monitored and documented testing consistency across laboratories and technicians.
CONCLUSION: Piloting and optimization, and establishment of a robust quality assurance/quality control program documented process consistency throughout the study and was essential in executing this large-scale multicenter study. This program supports the validity of the RBC-Omics study results and a sample repository that can be used in future studies.
conducted the RBC-Omics study, a large multicenter study to define the genetic and metabolic basis for donorspecific differences in spontaneous, osmotic, and oxidative RBC hemolysis at the end of storage. 1 These aims required a study design to enroll donors in multiple categories including race/ethnicity, sex, and prior donation intensity, with sufficient numbers and diversity to power the multifaceted approach to meaningfully assess heritable differences in RBC propensity to hemolyze during storage.
Large clinical studies such as this are challenging and require steps to ensure success including pilot studies prior to study initiation and an ongoing quality assessment program during the prospective evaluation period to ensure high quality of data collection. The large-scale study scope necessitated that sample collection and associated procedures would have minimal impact on regular blood center operations. Highthroughput assays to measure RBC hemolysis parameters in stored RBCs over time under identical blood bank conditions using four assays in two laboratories were developed and required understanding and monitoring of parameters influencing variability in assay performance as well as establishment of sufficient and therefore uninterrupted testing capacity. The multifaceted approach of the study, collaborating with experts across diverse fields, necessitated that samples be of sufficient quality for planned genetic and metabolomic studies and for the establishment of a repository of well-characterized samples with documented quality for future studies.
Pilot studies were used to evaluate and validate key study procedures, as well as optimize assay performance, reproducibility, and yield. These studies included evaluation of transfer bags for sampling RBC parent units, elution of WBCs from leukoreduction (LR) filters for genetic studies, and the impact of sample preparation and manufacturing methods on hemolysis measures. Quality assessment and proficiency testing were performed throughout the study to assess the consistency in laboratory data and to identify causes of and strategies to minimize laboratory variation (Fig. S1 , available as supporting information in the online version of this paper). As a requirement for the study, a formal Manual of Procedures was developed documenting standardized operating procedures and specifications for quality assurance of all aspects of the study, ensuring consistency across sites and data collection for current and future analyses. Here, we describe the systems implemented to ensure the reliability of data entering the analytic pipeline and to substantiate the integrity of study outcomes and enable future research programs capitalizing on the sample and linked database generated as part of the RBC-Omics study.
MATERIALS AND METHODS

Overview of screening phase
The RBC-Omics cohort was recruited from four large blood centers across the United States, including the 
Evaluation of hemolytic propensity in stored RBCs
Spontaneous hemolysis of stored RBC samples was determined by comparing the supernatant hemoglobin to total hemoglobin concentration, and correcting for the hematocrit as previously described. 1, 3 Similarly, stress-induced hemolysis was measured by subjecting washed RBC samples to osmotic, mechanical, and oxidative stress and determining supernatant cell-free hemoglobin levels by the Drabkin method as previously described. Quality control testing to assess within and between laboratory assay performance during the study
To monitor the consistency of results among technicians and between laboratories during the course of the study, hematocrit and hemolysis results were routinely analyzed in real time. Additionally, a monthly panel of leukoreduced RBC transfer bags from three expired units (four replicates from each unit) was created at one REDS-III blood center (BCW) and sent to both testing labs for ongoing proficiency testing by laboratory personnel; transfer bags were assayed for hematocrit, spontaneous, osmotic, and oxidative hemolysis and mechanical fragility. The results from individual technicians in the two testing labs were compiled and analyzed over time and used to assess variability and alignment to predefined range (coefficient of variation <10%) for each of the measurements, and if discrepancies were noted, to determine if corrective action such as additional training or preparation of new reagents was required to bring results into range.
WBC recovery and preparation for DNA extraction and use in genomic studies Leukoreduction filter elution optimization for DNA recovery. To optimize recovery and concentration of DNA isolated from LR filters for downstream genome-wide association study and sequencing (which require ≥10 μg of DNA), elution of WBCs was evaluated under different conditions. First, to estimate recovery of eluted WBCs and isolated DNA from LR filters, 60 mL of phosphate-buffered saline (PBS) was back-flushed through 15 LR filters, 4 and recovered cells were counted and extracted DNA concentrations were measured by picogreen and nanodrop. To determine if forward flushing filters would reduce RBC contamination and increase WBC recovery, forward flushing of 20, 40, and 60 mL of PBS was performed on three LR filters under each condition. To determine if reduced elution volume would increase DNA yield and concentration, filters were back-flushed with 3 × 20-mL pulses of PBS and sampled at each pulse. Eluted cells for all conditions were centrifuged at 900g for 15 minutes, resuspended in 15 mL of PBS and counted, and 1-mL aliquots were made for DNA isolation. WBC counts and DNA yield and concentrations were compared for each condition to determine the optimal protocol for DNA recovery. Sequencing was performed on six pilot samples to determine if piloted sample preparation methods yielded samples of sufficient quality for downstream sequencing.
Impact of LR filter storage time and temperature.
Forty-five LR filters were retrieved from regular whole blood donations and stored at room temperature for 24 hours after collection and then processed or placed in storage at either room temperature or at 4 C. Five filters from each storage condition (room temperature and 4 C) were processed at 24-hour intervals up to 120 hours. Elution of WBC from filters was performed by flushing 40 mL of buffered saline through the filters, and cells were centrifuged at 900g for 15 minutes and resuspended in 15 mL of PBS, and 1-mL aliquots were made for DNA isolation and assessment of yield.
Optimization of freezing conditions for samples used in metabolomic studies Impact of freezing on adenosine triphosphate concentration. To determine the correlation between adenosine triphosphate (ATP) in RBC samples that were stored in liquid state at 1 to 6 C (standard sample method) or frozen at −80 C (RBC-Omics proposed method to allow batch testing) until processed for assays, 14 replicate samples (7 fresh and 7 frozen) were derived from each of 15 transfer bags at Day 42 of storage. Fresh and frozen samples were shipped overnight and fresh (liquid) samples were processed immediately upon arrival and stored with frozen samples at -80 C until assayed for ATP as previously described.
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Impact of freezing method on metabolomics results. Planned metabolomics studies required preparation of samples that were high quality, but study design necessitated high-throughput preparation. Snap freezing in liquid nitrogen is the gold standard but is impractical for all aspects of the study. Thus, it was necessary to determine the impact of the freezing method. To determine if a sample freezing method would impact metabolomics analysis, replicate aliquots aliquots of RBC were made of 15 transfer bags derived from end of storage pRBC units and frozen by three methods: snap frozen in liquid nitrogen, snap frozen in ethanol and dry ice, and placement directly into -80 C. All samples were stored and shipped at -80 C after initial freezing. Targeted metabolomics was performed to determine relative detection of 30 selected metabolites in samples frozen by different methods at Bloodworks Northwest Research Institute using methods previously described. 6 
Statistical analysis
All data were compiled and analyzed with computer software (Prism 6.0, GraphPad). Group analyses were performed using analysis of variance (Kruskal-Wallis). Comparisons were logtransformed and analyzed using Pearson correlation.
RESULTS Leukoreduction filter elution optimization
Several experiments to optimize the recovery of WBCs and reduce RBC contamination were performed. Initially using previously published methods, 4,7 60 mL of PBS was back-flushed through 15 LR filters, an average of 1.6 × 10 9 total WBC was recovered, corresponding to 26.9 × 10 6 cells and 66 μg DNA/mL of eluate (Fig. 1) . To determine if reducing the elution volume would increase the concentration of recovered WBCs and DNA, filters were back-flushed with 3 × 20-mL pulses of PBS and sampled at each 20-mL pulse. For each 20-mL back-flush, the average cell and DNA concentration was 14.2 × 10 6 cells/mL and 47.6 μg DNA/mL, 3.5 × 10 6 cells/mL and 15.3 μg DNA/mL, and 1.6 × 10 6 cells/mL and 9.9 μg DNA/mL, respectively. The second 20-mL back-flush reduced the per-milliliter yield of DNA by an average of 36.5%, and third by a further 67.1%, demonstrating that the majority of material was recovered after the first two pulses; thus, to minimize technician time and reagents, 40-mL elution volume was determined to be optimal for study procedures. To assess the storage conditions for optimal cell and DNA recovery, LR filters were stored at room temperature and 4 C for up to 5 days, and total and viable eluted WBCs were counted. Recovery was variable over time for both storage conditions, but appeared most stable with 4 C storage but did not influence DNA recovery (Fig. 1) .
Forward flushing the filters to reduce RBC contamination did not improve recovery. DNA from 6 pilot samples was sequenced to ensure adequate quality for planned downstream genetic analysis. DNA was of high quality and suitable for exome and genotyping sequencing (Table 1 ). The quality of DNA recovered from LR filters through the course of the RBC-Omics Study was later confirmed based on the results of the genome-wide association study analysis as reported by Guo et al. Smaller volume Pedi-Paks were considered for study use to sample representative volume from parent leukoreduced RBC units. A study was done to assess differences in RBC parameters and hemolysis measures between RBCs stored in pediatric bags compared to parent leukoreduced RBC component bags and to confirm proposed sampling times for the study adequately represented the dynamics of hemolysis to cover fresh (approx. 7 days in comparable studies), midterm storage (21 days, representing the median range for transfused RBC products in the United States), and 42 days (maximum allowed storage period). RBC hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin concentration, and RBC distribution width were similar between parent units and Pedi-Pak bags. However, there was a consistent and statistically significant increase in spontaneous hemolysis in the Pedi-Pak compared to the parent bags (p < 0.001 at 42 days) (Fig. 2) . The mean osmotic fragility in the Pedi-Pak bags was lower than in the parent units and decreased in both bag types at 21 days before rising again. The Pedi-Pak bags demonstrated a slightly higher (but not statistically significant) increased sensitivity to oxidative hemolysis starting at 14 days of storage. Mechanical fragility increased in both bags between 21 and 42 days (p = 0.003 at Day 28 relative to Day 0). The lack of correlation between parent and pediatric bag hemolysis led to further study to identify a transfer bag with similar properties as the parent bag.
Evaluation of candidate transfer bags
Three custom transfer bags manufactured by Haemonetics using the same materials as the parent bags to eliminate potential issues related to plasticizers were evaluated (Fig. 3) . The results demonstrated improvement relative to the Pedi-Pak units where osmotic RBC hemolysis was significantly lower than in the parent leukoreduced RBC components. Oxidative hemolysis levels in the custom transfer bags were either similar or slightly higher than in the parent unit. Spontaneous storage hemolysis was similar between parent and transfer bags. Significant differences were not seen between parent and any of the candidate transfer bags and led to the selection of one of the transfer bags for use in the study.
Impact of manufacturing methods and comparison of transfer and parent bags
Routine monitoring of assay results among testing labs revealed differences in hemolysis parameters. After testing 731 study transfer bags, significant differences in spontaneous hemolysis were found between ITxM and the other sites (p < 0.005; Fig. 4 ). To determine if this difference was due to sample-handling differences across sites, we designed and executed a study to simulate handling differences and assess their impact on hemolysis in parent and transfer bags. Manipulated and static stored bags were compared for the five different leukoreduced RBC production methods used at the four donor center sites. We found that there were no differences across four sites, between the manipulated and stored transfer bags, or between the parent and transfer bags (Fig. S2 , available as supporting information in the online version of this paper).
Impact of freezing method on ATP concentration
ATP concentration was compared in replicate fresh and frozen samples prepared from 15 RBC transfer bags to determine if frozen samples could be used to enable batched testing of study samples. ATP concentration was determined to be measurable and was similar in fresh and frozen samples (r 2 = 0.852).
Impact of freezing method on RBC metabolites
Targeted metabolomics was performed on replicate samples frozen by different methods from 15 transfer bags to determine impact of freezing method on relative detection of 30 selected metabolites including oxylipins, polyunsaturated fatty acids, and lysophospholipids. These metabolites are known to be sensitive to oxidation and to accumulate during RBC storage resulting from the lipid oxidation/degradation. The results from the three freezing methods were very similar to each other, with relative standard deviations ranging from 0.2% to 6.9% (Table S1 , available as supporting information in the online version of this paper). However, significant differences were observed among the freezing methods for some metabolites. In particular, polyunsaturated fatty acids were lower with liquid nitrogen freezing and slightly increased for other methods, likely due to lipid degradation or oxidation during the freezing process. Fig. 5 shows relative comparisons among freezing methods for each metabolite.
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Quality control program
During routine monitoring of RBC hematocrit and hemolysis data for between lab and between technician differences, three factors were noted (Fig. S3a , available as supporting information in the online version of this paper): First, the distribution of hematocrits was lower at ITxM (UPMC) early in the study compared to VRI (p < 0.001) (data not shown).
Retraining of lab staff on assay procedures, particularly sufficient mixing of units prior to testing was provided and hematocrit increased to a consistent range across sites. Second, it was noted early in the study that spontaneous hemolysis values generated at the VRI laboratory were significantly higher than UPMC laboratory (p < 0.001) (Fig. 4) . A clip used to attach extra labels to the bag was identified and removed and the hemolysis values at VRI were subsequently in the range of UPMC. Finally, it was noted that there was a decrease in oxidative hemolysis values for RBC samples tested at VRI compared to UPMC during study days 50 to 100 (p < 0.001) (Fig. S3) . After investigation, it was determined that the oxidative hemolysis buffer was insufficiently mixed during preparation at UPMC. After this, more stringent criteria for prequalification of buffers were incorporated, including synchronized lot release and testing before use. Data impacted by these issues with assay performance were excluded from the final RBC-Omics Study analysis. Proficiency panels were sent out monthly to the testing laboratories to monitor assay performance and for retraining when results were out of expected ranges (example in Fig. S3b ). Across both testing sites the coefficient of variation for inter-and intralaboratory variation when testing the same RBC unit were calculated as 0.91% for hematocrit, 11.6% for spontaneous storage hemolysis, 14.7% for oxidative hemolysis, 19.0% for mechanical fragility, and 10.5% for osmotic hemolysis. Overall, there was good agreement, with the higher variation in storage and oxidative hemolysis possibly due to the expired units used for proficiency testing. There were no significant differences between testing laboratories for hematocrit, storage hemolysis, or osmotic hemolysis (2,2 0 -azobis-2-methyl-propanimidamide). There were significant differences in oxidative hemolysis (p = 0.02) and mechanical fragility (p < 0.001). The difference in oxidative hemolysis was due to the buffer production error (see above) and the difference in mechanical fragility was due to the difference in plate shaker model used between labs; the VRI mechanical fragility data impacted by these factors were not used in the analysis.
DISCUSSION
The REDS-III RBC-Omics study was designed to examine the impact of donor-specific genetic and metabolomic differences on propensity for in vitro hemolysis of stored RBCs in a large prospective and diverse cohort across four blood centers. 1 Such studies benefit from the diversity and generalizability that can be achieved in a large multicenter study, yet are challenged by potential differences in collection and processing methods at blood centers and storage conditions across sites. Large-scale studies call for high-volume testing capacity and often require multiple testing laboratories to increase study throughput and ensure redundancy in testing capacity. Pilot studies are a crucial element of good study design and fundamental to the evaluation of study approach feasibility. Ongoing quality assessment of data provides the opportunity to develop and implement practices that ensure the integrity of procedure execution, data collection, and interpretation. Piloting the capture of WBCs from LR filters, ensuring the quantity and quality of the extracted DNA, was necessary for the reliability of downstream genetic studies, a major aim of this study to delineate genetic determinants of storage hemolysis.
The study capitalized on routine available of LR filters from study participants' RBC donation, which allowed for recovery of WBCs from LR filters and provided a reliable source of high yields of WBCs and DNA for genetic studies. However, this required the implementation of procedures for consistent and efficient WBC recovery by multiple technicians at the four REDS-III sites. This process has since been validated as the RBC-Omics genome-wide association study results ultimately demonstrated that the extracted DNA was of excellent quality. 8 In addition, with large multicenter studies, building redundancy in testing capacity ensures that unanticipated gaps in testing resources at a single site can be covered. Ensuring comparable performance between testing labs assured reproducibility in testing methods and resulting data and accuracy of interpretation. This was assured through optimization and consistency of reagent control procedures, initial training and retraining where ongoing monitoring of data quality and consistency noted discrepancies, and through a quality control program including ongoing proficiency testing to assess assay performance between testing laboratories and technicians.
Substantial differences in levels of spontaneous storage hemolysis have been documented due to manufacturing differences. 9, 10 During the study we learned that the timing of LR at ITxM, which was delayed relative to the other hubs, correlated with increased levels of spontaneous hemolysis and was likely responsible for these observed differences. Similar studies suggest that storage hemolysis can be affected by other manufacturing procedures, such as manipulation of RBC units, the bag's plasticizer, or type of additive solution. 9, [11] [12] [13] [14] [15] [16] [17] Because the four REDS-III hubs used different manufacturing methods, it was necessary to 1) assess differences in hemolysis measures due to variability in hub-specific manufacturing methods and 2) determine if spontaneous and stress-induced hemolysis in the transfer bags was comparable to observations of these parameters in RBCs derived from the original leukoreduced RBC component. Pilot studies demonstrated that the type of RBC storage bag and manufacturing methods did indeed affect rates of hemolysis, and thus enabled understanding of these differences critical for appropriate interpretation of study findings to ensure that differences were appropriately attributed. Understanding the effects of storage variation may also lead to improvements in the quality of RBC products produced by different methods and stored in alternate bag types.
Higher levels of free hemoglobin and increased susceptibility to oxidative stress were found in pediatric bags; it would be of interest for future studies to evaluate whether this is correlated with an increase in transfusion reactions or effects on transfusion efficacy in recipients. 18, 19 The observed differences in hemolysis between the parent and pediatric bag may stem from the type of plasticizers used in each bag (butyryl trihexyl citrate in Pedi-Pak vs. bis(2-ethylhexyl) phthalate in parent units), or to differences in surface area-to-volume ratio of the different-sized bags. Differences in stress-induced hemolysis were not observed in the custom transfer bag that was ultimately used for the RBCOmics study. 20, 21 Preliminary studies of ATP for RBC-Omics were done using fresh RBC samples; however, the nature of the RBCOmics study necessitated batched testing of frozen samples. Thus, a pilot comparison of fresh versus frozen leukoreduced RBC samples was performed and determined that fresh and frozen samples were comparable with respect to ATP and thus could be used for the study.
Screening RBC samples were prepared by freezing at -80 C to facilitate high-throughput processing, while recall samples were prepared by snap freezing to ensure appropriate sample integrity for planned metabolomics analyses.
Comparisons among three freezing methods were done to determine impact on detection and levels of selected metabolites. Results showed that metabolites have varying sensitivity to freezing methods, which must be accounted for if future metabolomics analysis is planned using the screening phase samples which were initially frozen at -80 C rather than snap frozen in liquid nitrogen, followed by freezing in mechanical freezers at -80 C. Metabolomics analysis performed on recall samples demonstrated excellent sample quality. 22, 23 In conclusion, pilot studies and ongoing quality assurance and proficiency testing were required to optimize standardized operating procedures and to monitor reproducibility of assay performance in this large multicenter study. Toward this end, all study procedures and laboratory standardized operating procedures, which are archived in the RBC-Omics Manual of Procedures, are available upon request. This rigorous approach was instrumental in assuring highly reliable findings generated through the multifaceted RBC-Omics study design. The processes implemented and developed for this complex study can inform the design of similar large-scale studies focusing on the RBC storage lesion, as well as future studies capitalizing on the REDS-III RBC-Omics repository of samples and transfusion outcomes in recipients of RBC components derived from RBC-Omics' donors available in the REDS-III linked donor-recipient database. Table S1 . A. Mean detection by targeted metabolomics of 30 selected analytes (B) in 15 samples prepared by three freezing methods; C-80; placement in -80 C, DI/E; snap frozen in ethanol and dry ice, LN2; snap frozen in LN2. Pairwise t-test indicates significant differences between freezing methods for each analyte.
